Lyra Therapeutics Inc.

UEI
DK48JGAVNMJ1
CAGE
4PDS1
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Lyra Therapeutics Inc.'s 4 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Sbir topic 096:the development leading to the commercialization of a bioresorbable stents (BRS) for the treatment of… Contract · HHSN268201600041C National Heart Lung and Blood Institute $1,064,069
Novel bioabsorbable, flexible polymeric stent for pulmonary artery stenosis Grant · R44HL132197 National Heart Lung and Blood Institute $1,542,676
Sbir topic 079 phase i- bioabsorbable stents for pediatric pulmonary artery stenosis and aortic coarctation Contract · HHSN268201300063C National Heart Lung and Blood Institute $1,718,359
Research contract award proposal titled "self-expanding, tough biodegradable elastomers for wound stasis." Contract · W911NF10C0089 ACC Aberdeen Proving Ground $11,488,841

Quick answers

What is Lyra Therapeutics Inc.'s UEI?

Lyra Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is DK48JGAVNMJ1.

What is Lyra Therapeutics Inc.'s CAGE code?

Lyra Therapeutics Inc.'s CAGE code is 4PDS1.

What is Lyra Therapeutics Inc.'s primary NAICS code?

Lyra Therapeutics Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Is Lyra Therapeutics Inc. registered in SAM.gov?

Lyra Therapeutics Inc.'s SAM.gov registration expired on February 20, 2024.

What is Lyra Therapeutics Inc.'s most recent federal award?

Lyra Therapeutics Inc.'s most recent federal contract award is Sbir topic 096:the development leading to the commercialization of a bioresorbable stents (BRS) for the treatment of… (HHSN268201600041C), from National Heart Lung and Blood Institute, on September 27, 2016.

On GovTribe

See Lyra Therapeutics Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login